Skip to main content

Drug Therapy Guidelines Updates July 2020

Date:
July 24, 2020

New drug therapy guidelines have been developed with the guidance of our Pharmacy and Therapeutics Committee. These guidelines will be posted by August 1 and will be effective September 1. The following medications will require preauthorization:

  • Abraxane
  • Ergot Alkaloids*
  • Sitavig*
  • Tolsura*
  • Xiaflex*                                                                         

Recent Articles

  • Pregnancy During the COVID-19 Pandemic
    For many pregnant women, the COVID-19 pandemic has raised new questions about how to get the care they need while staying healthy. According to the Centers for Disease Control and Prevention (CDC), pregnant women might be at a higher risk for severe illness or hospitalization if they contract COVID-19 and they may need additional support during these unprecedented times. Here, we offer guidance and resources for your pregnant patients.
  • CDE-A Program Helps Diabetic Patients Lower A1C
    Our Certified Diabetes Educator Ambassador (CDE-A) program has helped diabetic patients lower their A1C by one full point. As the COVID-19 pandemic continues to raise challenges for people with chronic conditions, this program helps your BlueCross BlueShield patients manage their diabetes and overall health at no cost to them. Find out how your patients can benefit from this supportive program.
  • Reminder: Ancillary Claims Must Be Approved by Supervising Physician
    To ensure proper processing and avoid denials or rejections, ancillary claims, lab orders, specialty pharmacy prescriptions, and referrals for your BlueCross BlueShield patients must be completed in full by the supervising physician of record.
  • The Impact of COVID-19 on Diabetes in Our Community
    It has been widely reported that people with diabetes are especially vulnerable to serious complications from COVID-19 infection. Our webinar, “The Impact of COVID-19 on Diabetes in Our Community” featured local thought leaders to address this concern and offer diabetes care resources to Western New York providers. Here you can view the recording and learn more.
  • Drug Therapy Guidelines Updates July 2020
    New drug therapy guidelines have been developed with the guidance of our Pharmacy and Therapeutics Committee. These guidelines will be posted by August 1 and will be effective September 1. Five medications will require preauthorization.

Working with Us

Additional Resources

We want to hear from you! Have a topic request for the next Blue Bulletin? Email us

Stay in Touch! Sign up to receive emails for provider news and information